Table 1. Overview of Included Trials.9-14.
Name/Year | Chirapongsathorn, 2012 | Panahi, 2018 | Panahi, 2017 | Rahmani, 2016 | Navekar, 2017 |
---|---|---|---|---|---|
Design, Sample Size | DB, PC; n=20 | SA, OL; n=36 | DB, PC; n=87 | DB, PC; n=80 | DB, PC; n=46 |
Intervention | Curcumin (Dose NR) | Curcumin 1500mg/day | Curcumin 1000mg/day | Curcumin 500mg/day | Turmeric 3000mg/day |
Duration | 6 months | 8 weeks | 8 weeks | 8 weeks | 12 weeks |
Age | 53-57 years | 49 years | 45-47 years | 46-49 years | 40-42 years |
Gender | 55% Male | NR | 59% Male | 48% Male | 43% Male |
Country | Thailand | Iran | Iran | Iran | Iran |
DB = double blinded, OL = open label, NR = not reported, PC = placebo controlled, SA = single arm (no control group)